# Cytoflavin in the Complex Rehabilitation of Stroke Patients

> **NCT05935787** · PHASE3 · COMPLETED · sponsor: **POLYSAN Scientific & Technological Pharmaceutical Company** · enrollment: 240 (actual)

## Conditions studied

- Stroke

## Interventions

- **DRUG:** Cytoflavin (Inosine + Nicotinamide + Riboflavin + Succinic Acid)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05935787
- **Lead sponsor:** POLYSAN Scientific & Technological Pharmaceutical Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-06-30
- **Primary completion:** 2024-06-26
- **Final completion:** 2024-12-07
- **Target enrollment:** 240 (ACTUAL)
- **Last updated:** 2026-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05935787

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05935787, "Cytoflavin in the Complex Rehabilitation of Stroke Patients". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05935787. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*